The influence of ustekinumab on expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in patients with psoriasis and in a control

The aim of this study was to assess changes in the expression of STAT1, STAT3, STAT4, SOCS2, and IL17 in psoriatic patients under ustekinumab treatment and in healthy volunteers. The study group consisted of 14 patients suffering from psoriasis vulgaris qualified for ustekinumab therapy (4 women, 10...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Dermatologic therapy Jg. 32; H. 5; S. e13029 - n/a
Hauptverfasser:	Grabarek, Beniamin, Krzaczyński, Jakub, Strzałka‐Mrozik, Barbara, Wcisło‐Dziadecka, Dominika, Gola, Joanna
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Hoboken, USA John Wiley & Sons, Inc 01.09.2019
Schlagworte:	Adult Dermatologic Agents - pharmacology Female Gene Expression Regulation - drug effects Humans Interleukin-17 - biosynthesis Interleukin-17 - genetics JAK/STAT signaling pathway Male Middle Aged psoriasis Psoriasis - drug therapy Psoriasis - genetics Psoriasis - metabolism RNA - genetics Signal Transduction STAT1 Transcription Factor - biosynthesis STAT1 Transcription Factor - genetics STAT3 Transcription Factor - genetics STAT4 Transcription Factor - biosynthesis STAT4 Transcription Factor - genetics Suppressor of Cytokine Signaling Proteins - biosynthesis Suppressor of Cytokine Signaling Proteins - genetics ustekinumab Ustekinumab - pharmacology Young Adult psoriasis JAK/STAT signaling pathway ustekinumab
ISSN:	1396-0296, 1529-8019, 1529-8019
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!